Treatment of recalcitrant lupus erythematosus tumidus with deucravacitinib
JAAD Case Rep
.
2023 Dec 16:45:110-112.
doi: 10.1016/j.jdcr.2023.11.029.
eCollection 2024 Mar.
Authors
Arianna Zhang
1
2
,
Rebecca G Gaffney
2
,
Joseph F Merola
3
4
Affiliations
1
School of Medicine, Tufts University, Boston, Massachusetts.
2
Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
3
Department of Dermatology, UT Southwestern Medical Center, Dallas, Texas.
4
Division of Rheumatology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
PMID:
38439766
PMCID:
PMC10909655
DOI:
10.1016/j.jdcr.2023.11.029
No abstract available
Keywords:
Tyk2; autoimmune disease; cutaneous lupus erythematosus; deuravacitinib; treatment.
Publication types
Case Reports
Grants and funding
T32 TR004418/TR/NCATS NIH HHS/United States